Centre For Clinical Research And Biostatistics (CCRB)

Back

1 Unique Trial Number (assigned by CCRB)

CUHK_CCT00368

2 Trial Registration Date

2013-05-13

i Registration Status

Prospective

3 Secondary IDs

None

4 Source(s) of Funding

None

5 Primary Sponsor

Alex Pui Wai LEE

6 Secondary Sponsor

None

Function

Please specify

7 Responsible Contact Person (public contact person for patients interested in participating)

i Name

Alex Pui Wai LEE

ii Address

9/F, CSB, Department of Medicine and Therapeutics, PWH

iii Phone

26351299

iv Email

alexpwlee@cuhk.edu.hk

v Affiliation

The Chinese University of Hong Kong

vi Country

8 Research Contact Person (person to contact for scientific inquiries)

i Name

Chun-Na JIN

ii Address

Heart centre, 10/F, CSB, Department of Medicine and Therapeutics, PWH

iii Phone

67336702

iv Email

jinchunna@cuhk.edu.hk

v Affiliation

The Chinese University of Hong Kong

vi Country

9 Official Scientific Title of the Study

A Prospective Registry of Hypertension Treatment in Hong Kong

10 Public Title

A Prospective Registry of Hypertension Treatment in Hong Kong

i Public Title in Chinese 研究名稱

香港地區高血壓治療前瞻性研究

11 Short Title (Optional)

Hypertension Registry

12 Countries of Recruitment

Hong Kong

13 Research Ethic Review

i Has the study received appropriate ethics approval?

Yes

ii When is the approval date?

2013-04-12

iii Full Name of IRB/IEC

Please specify

iv IRB/IEC approval reference number

14 Medical Condition Being Studied

Hypertension

15 Intervention

i Types of intervention

Other

Please specify

None

ii Description/ name of Intervention/article

None

iii Dosage form of the intervention

iv Dosage of the intervention

v Duration of the intervention

None

vi Frequency of the intervention

16 Comparative Treatments

i Description/ name of comparative treatments

None

ii Dosage form of the comparative treatments

iii Dosage of the comparative treatments

iv Duration of the comparative treatments

v Frequency of the comparative treatments

17 Key Inclusion and Exclusion Criteria

i Inclusion Criteria

Patients diagnosis as hypertension before or current by experienced physician.

ii Exclusion Criteria

1. Patients who refuse to participate in the study.
2. Patients who cannot be adequately informed of the nature and risks of the study.

iii Age Minimum

18

iv Age Maximum

None

v Gender

Both Male and Female

18 Study Type

Observational

19 Study Design

i Randomization

Not Applicable

Please specify

ii Nature of control

Not Applicable

iii Degree of masking

Not Applicable

If Single-blind, who will be masked?

iv Group Assignment

Not Applicable

v Study Phase

Please specify

vi Study Objectives (Optional)

20 Anticipated trial start date

2013-05-22

21 Target Sample Size

1015

22 Recruitment Status

Unknown

23 Primary Outcome

1.Blood pressure at baseline
2.Proportioin of resistant hypertension at baseline
3.Quality of life score at baseline

24 Secondary Outcome

Cost-effectiveness analysis at 18th month

25 Study Information/Publication

i Study Information/Publication Available?

No

ii Link to Study Information/Publication

26 Last Update Date

2015-06-16

27 Primary Registry and Trial Identifying Number

ChiCTR-ONC-13003223

28 Date of Registration in Primary Registry

2013-05-16

* Legacy Fields

i Recruitment Information Available?

Yes

ii Link to Recruitment Information

None

Back

Trial History Detail on 2015-06-16